Completed
Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host
NCT02891395
- Conditions
- Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
- Locations
-
- CHU Sart Tilman Liège, Belgium
- CHU d'Amiens Amiens, France
- CHU d'Angers Angers, France
- CHU Besançon Besançon, France